NHS Brings Cervical Screening Home With Free HPV Testing Kits

A new NHS initiative is giving thousands of women in England another way to take part in cervical screening. From 25 August 2026, eligible women who have repeatedly missed screening appointments can be offered a free HPV self-testing kit that allows them to collect a sample at home.

The move is designed to tackle one of the biggest challenges facing the cervical screening programme: getting people who are overdue for screening to participate. Current NHS figures show that 68.8% of eligible women in England are up to date with screening, below the NHS target of 80%. As a result, around four million women are estimated to be overdue.

A simpler approach to screening

The new home testing option uses a small swab to collect a sample from the vagina. The sample is then returned to the NHS, where it is tested for high-risk types of human papillomavirus, commonly known as HPV.

HPV is extremely common and can be transmitted through sexual contact. Most infections do not cause serious problems and clear naturally, but certain high-risk types can cause changes in cervical cells. If these changes are left untreated, they can eventually develop into cervical cancer.

The important point is that the home test looks for HPV rather than directly checking cervical cells. If high-risk HPV is detected, the person will be invited to attend a follow-up appointment with a healthcare professional. A nurse or doctor can then take a conventional cervical sample to look for abnormal cells.

This means the home test is not intended to replace the traditional screening appointment for everyone. Instead, it is being introduced as an additional option for people who have not responded to previous invitations.

Why the change matters

Cervical screening can prevent cancer by identifying high-risk HPV and detecting cell changes before they become cancerous. However, simply offering screening is not enough if people find it difficult to attend appointments.

There can be many reasons for missing screening. Some people may feel embarrassed about an intimate examination. Others may be worried about discomfort, have difficulty finding time for an appointment, or have previous experiences that make medical examinations particularly difficult.

Home testing could remove some of these barriers. A person can collect the sample privately rather than attending a clinic for the initial test. For some people, that difference could be enough to encourage them to take part.

NHS England describes the initiative as a major opportunity to improve participation. The programme will initially focus on eligible women aged 30 to 65 who have not attended screening after previous invitations. Invitations can be sent through the NHS App, text message, email or post. Those invited can then order a free test through the NHS App or their NHS online account.

Evidence behind the programme

The national rollout follows research into HPV self-sampling, including the YouScreen trial carried out in London.

According to NHS England, the trial found that offering self-testing to women who were under-screened could increase participation significantly. The research suggested that the approach could result in roughly 400,000 additional women being screened each year if implemented across England. Evidence from the trial contributed to the UK National Screening Committee's recommendation to expand the approach.

London has already been gaining experience with HPV self-sampling. NHS England London says the programme became available across all London GP practices in 2026, following earlier phases involving selected practices and other healthcare settings. The regional programme is aimed particularly at women and people with a cervix who rarely attend or have never attended cervical screening.

This earlier experience provides an opportunity to understand how people respond to self-sampling before and during the wider national rollout.

What happens after a home test?

The process is relatively straightforward, but the result determines what happens next.

If no high-risk HPV is detected, the person will generally continue within the normal screening pathway. If high-risk HPV is found, further assessment is required. The person will be asked to attend a healthcare appointment, where a clinician can collect a cervical sample and examine the cells for abnormalities.

This follow-up stage is important because finding HPV does not mean that someone has cervical cancer. HPV infection is common, and a positive result indicates the need for further assessment rather than a cancer diagnosis.

People should therefore view the self-test as one part of a screening pathway, not as a complete replacement for medical care.

Traditional screening still has an important role

The NHS has made clear that people who routinely attend cervical screening should continue to do so.

Clinician-led screening remains an important part of the programme because it allows healthcare professionals to collect a sample directly from the cervix. The new self-sampling option is primarily intended to reach people who are not engaging with routine screening.

The distinction is important. The aim is not simply to make everyone switch from clinic-based screening to home testing. Instead, the priority is to reach people who might otherwise receive no screening at all.

NHS guidance also stresses that HPV vaccination does not eliminate the need for cervical screening. The vaccine protects against important types of HPV, but it does not protect against every type that can contribute to cervical cancer.

Part of a wider cancer prevention strategy

The introduction of home HPV testing is connected to a broader NHS ambition to eliminate cervical cancer as a public health problem in England by 2040.

That goal depends on several measures working together. HPV vaccination helps prevent infection with important high-risk types of the virus. Cervical screening can identify HPV and detect changes before they develop into cancer. Early diagnosis and treatment can then prevent disease from progressing.

Improving screening participation is therefore a crucial part of the strategy.

The challenge is reaching people who do not engage with conventional healthcare services. Making screening more convenient may help close some of that gap, although the long-term impact will depend on how many people accept the offer, return their samples and attend follow-up appointments when necessary.

What this means for patients

For people in England who receive an invitation, the new service could make taking the first step towards screening much easier. The sample can be collected privately at home and returned to the NHS for testing without the need for an initial clinic appointment.

However, anyone who receives an invitation should read the instructions carefully and complete the test according to the NHS guidance. A positive HPV result should not be interpreted as a diagnosis of cancer, but it does mean that follow-up is important.

People who have missed a previous screening appointment do not necessarily need to wait for a new invitation before seeking care. NHS guidance says that someone who has been invited for screening can still contact their GP surgery or a sexual health clinic to arrange an appointment.

The new home testing programme is therefore best understood as another route into the screening system, particularly for people who have struggled with conventional appointments.

If it succeeds in reaching people who have previously stayed away from screening, it could become an important tool in reducing preventable cervical cancer. Its biggest potential benefit may be simple: making a potentially lifesaving test easier to access for people who have found traditional screening difficult.

Sources: NHS England, NHS rolls out discreet home-testing kits against cervical cancer for millions of women, 25 August 2026; NHS England London, Cervical screening resources; NHS, How to book cervical screening.

Disclaimer: This article is for general information only and is not medical advice. Cervical screening recommendations can vary according to individual circumstances. Anyone who receives an NHS screening invitation, has concerns about symptoms, or is unsure what to do after an HPV result should follow NHS instructions and speak with an appropriate healthcare professional.